These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10967445)

  • 1. Preparation in high-shear mixer of sustained-release pellets by melt pelletisation.
    Voinovich D; Moneghini M; Perissutti B; Filipovic-Grcic J; Grabnar I
    Int J Pharm; 2000 Aug; 203(1-2):235-44. PubMed ID: 10967445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of a melt pelletised paracetamol/stearic acid sustained release delivery system.
    Grassi M; Voinovich D; Moneghini M; Franceschinis E; Perissutti B; Filipovic-Grcic J
    J Control Release; 2003 Mar; 88(3):381-91. PubMed ID: 12644364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and evaluation of prolonged release pellets obtained by the melt pelletization process.
    Hamdani J; Moës AJ; Amighi K
    Int J Pharm; 2002 Oct; 245(1-2):167-77. PubMed ID: 12270253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of sustained release matrix pellets by melt agglomeration in the fluidized bed: influence of formulation variables and modelling of agglomerate growth.
    Pauli-Bruns A; Knop K; Lippold BC
    Eur J Pharm Biopharm; 2010 Mar; 74(3):503-12. PubMed ID: 20026401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of spherical pellets by a hot-melt extrusion and spheronization process.
    Young CR; Koleng JJ; McGinity JW
    Int J Pharm; 2002 Aug; 242(1-2):87-92. PubMed ID: 12176229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of melt extruded enteric matrix pellets.
    Schilling SU; Shah NH; Waseem Malick A; McGinity JW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro release of theophylline from poly(lactic acid) sustained-release pellets prepared by direct compression.
    Kader A; Jalil R
    Drug Dev Ind Pharm; 1998 Jun; 24(6):527-34. PubMed ID: 9876618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
    Ghanam D; Kleinebudde P
    Int J Pharm; 2011 May; 409(1-2):9-18. PubMed ID: 21335073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique II. In vitro drug release studies and release mechanisms.
    Cheboyina S; Wyandt CM
    Int J Pharm; 2008 Jul; 359(1-2):167-73. PubMed ID: 18495391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique I. Formulation and process variables affecting pellet characteristics.
    Cheboyina S; Wyandt CM
    Int J Pharm; 2008 Jul; 359(1-2):158-66. PubMed ID: 18499369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation on drug dissolution and particle characteristics of pellets related to manufacturing process variables of high-shear granulation.
    Dévay A; Mayer K; Pál S; Antal I
    J Biochem Biophys Methods; 2006 Nov; 69(1-2):197-205. PubMed ID: 16650480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: level A in vitro-in vivo correlation.
    Ochoa L; Igartua M; Hernández RM; Solinís MA; Gascón AR; Pedraz JL
    Eur J Pharm Biopharm; 2010 Jun; 75(2):232-7. PubMed ID: 20159037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melt pelletisation of a hygroscopic drug in a high shear mixer. Part 1. Influence of process variables.
    Thies R; Kleinebudde P
    Int J Pharm; 1999 Oct; 188(2):131-43. PubMed ID: 10518669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of sustained release co-extrudates by hot-melt extrusion and mathematical modelling of in vitro/in vivo drug release profiles.
    Quintavalle U; Voinovich D; Perissutti B; Serdoz F; Grassi G; Dal Col A; Grassi M
    Eur J Pharm Sci; 2008 Mar; 33(3):282-93. PubMed ID: 18280119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization.
    Hamdani J; Moës AJ; Amighi K
    Int J Pharm; 2006 Sep; 322(1-2):96-103. PubMed ID: 16824707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of production variables on the sphericity of melt pellets.
    Heng PW; Wong TW; Chan LW
    Chem Pharm Bull (Tokyo); 2000 Mar; 48(3):420-4. PubMed ID: 10726869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of physicochemical factors on the release kinetics of hydrophilic drugs from poly(L-lactic acid) (L-PLA) pellets.
    Kader A; Jalil R
    Drug Dev Ind Pharm; 1998 Jun; 24(6):535-9. PubMed ID: 9876619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of sustained-release lipophilic calcium stearate pellets via hot melt extrusion.
    Roblegg E; Jäger E; Hodzic A; Koscher G; Mohr S; Zimmer A; Khinast J
    Eur J Pharm Biopharm; 2011 Nov; 79(3):635-45. PubMed ID: 21801834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and In Vitro-In Vivo Evaluation of Sustained-Release Matrix Pellets of Capsaicin to Enhance the Oral Bioavailability.
    Zhang Y; Huang Z; Omari-Siaw E; Lu S; Zhu Y; Jiang D; Wang M; Yu J; Xu X; Zhang W
    AAPS PharmSciTech; 2016 Apr; 17(2):339-49. PubMed ID: 26127010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.